These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3143630)

  • 21. Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.
    Cushing T; Clericuzio CL; Wilson CS; Taub JW; Ge Y; Reichard KK; Winter SS
    J Pediatr; 2006 May; 148(5):687-9. PubMed ID: 16737888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cytogenetic analysis of cellular evolutions in leukemia].
    Motomura S; Ogi K
    Rinsho Ketsueki; 1973 Feb; 14(2):142-9. PubMed ID: 4513546
    [No Abstract]   [Full Text] [Related]  

  • 23. High reliability and sensitivity of the BCR/ABL1 D-FISH test for the detection of BCR/ABL rearrangements.
    Pelz AF; Kröning H; Franke A; Wieacker P; Stumm M
    Ann Hematol; 2002 Mar; 81(3):147-53. PubMed ID: 11904740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of myeloproliferative disorders using cell markers in culture.
    Adamson JW
    Haematol Blood Transfus; 1979; 23():205-10. PubMed ID: 544361
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diagnostic and pathogenetic significance of some cytogenetic and cythochemical findings (leukocyte alkaline phosphatase) in systemic hemopathies with myeloproliferative tendencies].
    Cacciola E; Giustolisi R
    Haematologica; 1970; 55(5):311-32. PubMed ID: 4995787
    [No Abstract]   [Full Text] [Related]  

  • 26. [Monoclonal origin of chronic myeloproliferative syndromes].
    Cervantes F
    Med Clin (Barc); 1983 Dec; 81(19):853-5. PubMed ID: 6656463
    [No Abstract]   [Full Text] [Related]  

  • 27. Demonstration of somatic mutation and colonic crypt clonality by X-linked enzyme histochemistry.
    Griffiths DF; Davies SJ; Williams D; Williams GT; Williams ED
    Nature; 1988 Jun; 333(6172):461-3. PubMed ID: 3374587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular characterization of G6PD in 24 cases of enzimatic deficiency, description of a new variant (G6PD-Bética) (author's transl)].
    Vives Corrons JL; Pujades A; Curia MD
    Sangre (Barc); 1980; 25(6):1049-64. PubMed ID: 7221827
    [No Abstract]   [Full Text] [Related]  

  • 29. Recent developments on Mediterranean G6PD.
    Gaetani GF; Ferraris AM
    Br J Haematol; 1988 Jan; 68(1):1-2. PubMed ID: 3278730
    [No Abstract]   [Full Text] [Related]  

  • 30. Biochemical and cytochemical evaluation of heterozygote individuals with glucose-6-phosphate dehydrogenase deficiency.
    Gurbuz N; Aksu TA; Van Noorden CJ
    Acta Histochem; 2005; 107(4):261-7. PubMed ID: 16139339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal development from a progenitor with restricted differentiative expression in acute lymphoblastic leukemia.
    Ferraris AM; Canepa L; Massimo L; Dini G; Broccia G; Meloni T; Forteleoni G; Melani C; Gaetani GF
    Am J Hematol; 1985 Sep; 20(1):81-3. PubMed ID: 3861091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inv(1)(p22q25) in chronic myeloproliferative disease: constitutional or clonal defect?
    Wong KF; Wong WC; Cheuk W
    Cancer Genet Cytogenet; 2005 Apr; 158(2):188-91. PubMed ID: 15796968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Kurdish population of Western Iran.
    Rahimi Z; Vaisi-Raygani A; Nagel RL; Muniz A
    Blood Cells Mol Dis; 2006; 37(2):91-4. PubMed ID: 16938474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concluding remarks: nonmalignant clonal disorders II.
    Gordon-Smith EC
    Semin Hematol; 1991 Jan; 28(1):55-6. PubMed ID: 2017693
    [No Abstract]   [Full Text] [Related]  

  • 35. "Clonal" remission in acute leukemia.
    N Engl J Med; 1984 Oct; 311(14):922-3. PubMed ID: 6472412
    [No Abstract]   [Full Text] [Related]  

  • 36. Inactivated X chromosome fold in human leukemia and related clonal disorders.
    Avalos MR; Léonard C; Mielot F; Tchernia G
    Hum Genet; 1989 Jul; 82(4):386-8. PubMed ID: 2737671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Frequency of changes involving A, B, and P1 erythrocyte antigens in myelomonocytic syndromes in children].
    Reviron J; Schenmetzler C; Weisgerber C; Bernard J
    Rev Fr Transfus; 1970 Sep; 13(3):251-9. PubMed ID: 5278232
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeting Rho associated kinases in leukemia and myeloproliferative neoplasms.
    Mali RS; Kapur R
    Oncotarget; 2012 Sep; 3(9):909-10. PubMed ID: 23006984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic heterogeneity within clones of fetal human cells.
    Gilbert SF; Axelman J; Migeon BR
    Am J Hum Genet; 1981 Nov; 33(6):950-6. PubMed ID: 7325158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Activity of glucose-6-phosphate dehydrogenase in the bone marrow cells in children with acute leukemia].
    Portugalova VV
    Pediatriia; 1969 Feb; 48(2):68-71. PubMed ID: 5822195
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.